Walleye Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Walleye Capital's RGEN Position: Q1 2026 in Review
Walleye Capital sold out of Repligen (RGEN) in Q1 2026, closing a stake of 417,110 shares — an estimated $68.3M sold.
Walleye Capital first reported a position in RGEN in Q2 2019 and held it in 15 quarters. The position peaked at $68.3M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Walleye Capital reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
- Walleye Capital sold 417,110 Repligen shares in Q1 2026, an estimated $68.3M.
- Walleye Capital first reported a position in Repligen in Q2 2019 and held it in 15 quarters.
- Walleye Capital's Repligen position peaked at $68.3M in Q4 2025.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.